Detalles de la búsqueda
1.
Prefusion F Protein-Based Respiratory Syncytial Virus Immunization in Pregnancy.
N Engl J Med
; 386(17): 1615-1626, 2022 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35476650
2.
Multicenter surveillance of Streptococcus pneumoniae isolates from middle ear and mastoid cultures in the 13-valent pneumococcal conjugate vaccine era.
Clin Infect Dis
; 60(9): 1339-45, 2015 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25648240
3.
A Phase Three Study of the Safety and Immunogenicity of a Four-dose Series of 20-Valent Pneumococcal Conjugate Vaccine in Healthy Infants.
Pediatr Infect Dis J
; 43(6): 596-603, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38535409
4.
Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease After Introduction Into Routine Pediatric Use.
J Pediatric Infect Dis Soc
; 10(2): 141-150, 2021 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32415771
5.
Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial.
Lancet Infect Dis
; 21(2): 263-274, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32891191
6.
Lack of association of Kawasaki disease after immunization in a cohort of infants followed for multiple autoimmune diagnoses in a large, phase-4 observational database safety study of 7-valent pneumococcal conjugate vaccine: lack of association between Kawasaki disease and seven-valent pneumococcal conjugate vaccine.
Pediatr Infect Dis J
; 28(5): 438-40, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19319016
7.
National impact of 13-valent pneumococcal conjugate vaccine on ambulatory care visits for otitis media in children under 5â¯years in the United States.
Int J Pediatr Otorhinolaryngol
; 119: 96-102, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30690309
8.
Effectiveness of 13-valent pneumococcal conjugate vaccination for protection against acute otitis media caused by Streptococcus pneumoniae in healthy young children: a prospective observational study.
Lancet Child Adolesc Health
; 2(8): 561-568, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30119715
9.
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine (PCV13) formulated with 2-phenoxyethanol in multidose vials given with routine vaccination in healthy infants: An open-label randomized controlled trial.
Vaccine
; 35(24): 3256-3263, 2017 05 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-28479175
10.
A randomized study of fever prophylaxis and the immunogenicity of routine pediatric vaccinations.
Vaccine
; 35(15): 1926-1935, 2017 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28262330
11.
Circulating Antibody 1 and 2 Years After Vaccination With the 13-Valent Pneumococcal Conjugate Vaccine in Preterm Compared With Term Infants.
Pediatr Infect Dis J
; 36(3): 326-332, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27902652
12.
Streptococcus pneumoniae: description of the pathogen, disease epidemiology, treatment, and prevention.
Pharmacotherapy
; 25(9): 1193-212, 2005 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16164394
13.
13-valent pneumococcal conjugate vaccine (PCV13) in preterm versus term infants.
Pediatrics
; 135(4): e876-86, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25780077
14.
Decreased immune response to pneumococcal conjugate vaccine after 23-valent pneumococcal polysaccharide vaccine in children.
Vaccine
; 32(3): 417-24, 2014 01 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-24300594
15.
Safety experience with heptavalent pneumococcal CRM197-conjugate vaccine (Prevenar) since vaccine introduction.
Vaccine
; 27(25-26): 3281-4, 2009 May 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-19200818
16.
Prevenar vaccination: review of the global data, 2006.
Vaccine
; 25(16): 3085-9, 2007 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-17287048
17.
Challenges in estimating efficacy against pneumococcal pneumonia in children.
Pediatr Infect Dis J
; 31(4): 426; author reply 426, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22418656
18.
Decreased vancomycin susceptibility of coagulase-negative staphylococci in a neonatal intensive care unit: evidence of spread of Staphylococcus warneri.
J Clin Microbiol
; 41(10): 4660-5, 2003 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-14532199
Resultados
1 -
18
de 18
1
Próxima >
>>